[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate

C40H50O3 — CID 99573695

IUPAC[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H]2[C@@H](CC[C@H]3C[C@@H](C(C)=O)CC[C@@]32C)[C@@H]2CC[C@H](/C(C)=C/C=C(c3ccccc3)c3ccccc3)[C@@]12C
InChIInChI=1S/C40H50O3/c1-26(16-18-33(29-12-8-6-9-13-29)30-14-10-7-11-15-30)35-20-21-36-34-19-17-32-24-31(27(2)41)22-23-39(32,4)37(34)25-38(40(35,36)5)43-28(3)42/h6-16,18,31-32,34-38H,17,19-25H2,1-5H3/b26-16+/t31-,32-,34-,35+,36-,37-,38-,39-,40+/m0/s1
InChIKeyDUHXRILIXFGISQ-NTKOLFJFSA-N
MW578.84 g/mol
LogP9.47
Rot. Bonds6

About [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate

[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate (PubChem CID 99573695) has the molecular formula C40H50O3 and a molecular weight of 578.84 g/mol. Its IUPAC name is [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate.

Molecular Properties

Compound Name[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate
PubChem CID99573695
Molecular FormulaC40H50O3
Molecular Weight578.84 g/mol
Exact Mass578.38
IUPAC Name[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H]2[C@@H](CC[C@H]3C[C@@H](C(C)=O)CC[C@@]32C)[C@@H]2CC[C@H](/C(C)=C/C=C(c3ccccc3)c3ccccc3)[C@@]12C
InChIInChI=1S/C40H50O3/c1-26(16-18-33(29-12-8-6-9-13-29)30-14-10-7-11-15-30)35-20-21-36-34-19-17-32-24-31(27(2)41)22-23-39(32,4)37(34)25-38(40(35,36)5)43-28(3)42/h6-16,18,31-32,34-38H,17,19-25H2,1-5H3/b26-16+/t31-,32-,34-,35+,36-,37-,38-,39-,40+/m0/s1
InChIKeyDUHXRILIXFGISQ-NTKOLFJFSA-N
XLogP9.47
TPSA43.37 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500578.84
LogP ≤ 59.47
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate?
The IUPAC name of [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate (CID 99573695) is [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate.
What is the SMILES notation for [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate?
The canonical SMILES for [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate is CC(=O)O[C@H]1C[C@H]2[C@@H](CC[C@H]3C[C@@H](C(C)=O)CC[C@@]32C)[C@@H]2CC[C@H](/C(C)=C/C=C(c3ccccc3)c3ccccc3)[C@@]12C.
What is the InChIKey of [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate?
The InChIKey is DUHXRILIXFGISQ-NTKOLFJFSA-N. The full InChI is InChI=1S/C40H50O3/c1-26(16-18-33(29-12-8-6-9-13-29)30-14-10-7-11-15-30)35-20-21-36-34-19-17-32-24-31(27(2)41)22-23-39(32,4)37(34)25-38(40(35,36)5)43-28(3)42/h6-16,18,31-32,34-38H,17,19-25H2,1-5H3/b26-16+/t31-,32-,34-,35+,36-,37-,38-,39-,40+/m0/s1.
What are the key properties of [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate?
[(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate has a molecular weight of 578.84 g/mol, XLogP of 9.47, 6 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,5S,8R,9S,10S,12S,13S,14S,17R)-3-acetyl-17-[(2E)-5,5-diphenylpenta-2,4-dien-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-12-yl] acetate is sourced from PubChem (CID 99573695), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).